Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) was $10.79 for the day, down -0.74% from the previous closing price of $10.87. In other words, the price has decreased by -$0.74 from its previous closing price. On the day, 1.92 million shares were traded.
Ratios:
Our analysis of SPRY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on February 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $40.
Raymond James Upgraded its Outperform to Strong Buy on August 13, 2024, whereas the target price for the stock was revised from $18 to $22.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Shawver Laura bought 50,000 shares for $11.00 per share.
Shawver Laura sold 50,000 shares of SPRY for $615,565 on Feb 03 ’25. The Director now owns 210,346 shares after completing the transaction at $12.31 per share. On Feb 03 ’25, another insider, Shawver Laura, who serves as the Director of the company, bought 50,000 shares for $12.31 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 408.03 while its Price-to-Book (P/B) ratio in mrq is 5.22.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $7.55. The 50-Day Moving Average of the stock is -8.84%, while the 200-Day Moving Average is calculated to be -10.98%.
Shares Statistics:
A total of 97.15M shares are outstanding, with a floating share count of 51.30M. Insiders hold about 47.22% of the company’s shares, while institutions hold 50.59% stake in the company.
Earnings Estimates
The company has 2.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.12 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.16 and -$0.76 for the fiscal current year, implying an average EPS of -$0.56. EPS for the following year is -$0.35, with 4.0 analysts recommending between $0.64 and -$1.2.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $14M. There is a high estimate of $31M for the next quarter, whereas the lowest estimate is $7.1M.
A total of 4 analysts have provided revenue estimates for SPRY’s current fiscal year. The highest revenue estimate was $59.1M, while the lowest revenue estimate was $6M, resulting in an average revenue estimate of $20.82M. In the same quarter a year ago, actual revenue was $30kBased on 5 analysts’ estimates, the company’s revenue will be $124.5M in the next fiscal year. The high estimate is $197.1M and the low estimate is $82M.
